Search Results 921-930 of 15934 for Residual

1. Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer - Mayo Clinic

   At least 1 pathologically confirmed positive lymph node. No evidence of residual involved lymph node disease. Synchronous primary colon cancer allowed; No ...

2. Publications - Shannon P. Sheedy, M.D. - Mayo Clinic

   Can MRI radiomics distinguish residual adenocarcinoma from acellular mucin in treated rectal cancer? ... Models to predict outcomes after primary debulking ...

3. Cross-sectional, Multinational, Noninterventional Study to Evaluate the Psychometric Comparability of Culturally Adapted Versions of the Global Preclinical Alzheimer’s Cognitive Composite (G-PACC) - Mayo Clinic

   traumatic brain injury with residual neurological deficit; stroke or transient ischemic attack;. seizures (excluding febrile seizures in childhood); ...

4. Study of Efficacy and Safety of CTL019 in Adult ALL Patients - Mayo Clinic

   Administration of any T cell lytic or toxic agent (e.g. alemtuzumab) is strongly discouraged since residual lytic levels may destroy T-cells in the ...

5. A Study to Compare Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian or Primary Peritoneal Cancer - Mayo Clinic

   ... residual disease/nodule) or suboptimal residual disease (> 1 cm diameter residual disease/nodule) status allowed. Patients must have undergone a bilateral ...

6. A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate Is Effective in Preventing Asthma Exacerbations - Mayo Clinic

   * Participants with a confirmed infection with COVID-19 within 6 weeks prior to the screening visit, or with residual COVID-19 symptoms ("long COVID-19").

7. Niche Trial: Navigated Inhibitory rTMS to Contralesional Hemisphere Trial - Mayo Clinic

   previous stroke with residual deficits (TIAs not a reason for exclusion);; premorbid (retrospective) modified Rankin Scale (mRS) score ≥2 of any aetiology ...

8. Publications - Marina E. Giurescu, M.D. - Mayo Clinic

   Does magnetic resonance imaging accurately predict residual disease in breast cancer? Am J Surg. 2009 Oct; 198 (4):547-52. View PubMed; Grimsby GM, Gray R ...

9. Clinical trials - Oncology (Medical)

   A Study to Evaluate the Surgical Removal of Residual Brain Tumors Prior to Recurrence. Rochester, Minn. The purpose of this study is to evaluate the safety ...

10. Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery - Mayo Clinic

    Breast MRI not demonstrating a residual mass with rapid rise and washout type III kinetics. Note: A negative study (i.e., no evidence of abnormality) on ...